PTCT
PTC Therapeutics (PTCT)
NASDAQ
$82.20+$1.24 (+1.53%)
Price as of Jun 23, 2026 6:42 PM EDT
  • $6.7B
    Market Cap
  • 63.23%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
BLACKROCK, INC.
15.61%
12.9M
+169,652 (+1.31%)
Mar 31, 2026
VANGUARD GROUP INC
10.61%
8.8M
+514,204 (+5.84%)
Dec 31, 2025
WELLINGTON MANAGEMENT CO LLP
9.83%
8.2M
-611,780 (-7.50%)
Dec 31, 2021
BLACKROCK FUNDING, INC. /DE
9.52%
7.9M
-84,412 (-1.07%)
Dec 31, 2024
BLACKROCK INC.
9.37%
7.8M
+207,054 (+2.66%)
Jun 30, 2024
RTW INVESTMENTS, LP
9.34%
7.7M
0 (0.00%)
Mar 31, 2026
JANUS HENDERSON GROUP PLC
8.67%
7.2M
+2.3M (+32.56%)
Mar 31, 2026

Current Ownership Distribution

  • Institutions1.5B (59.20%)
  • Mutual Funds997.6M (40.60%)
  • Insiders4.8M (0.20%)
  • Other0 (0.00%)

Insider Transactions

  • 0.20% (4.8M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 12
    Number of InsiderSelling (last 12 months)
  • $915.3M
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Boulding Mark Elliott
EXEC. VP AND CLO
Exempt
Jun 17, 2026
$0.00
8,510
$0.00
32,950
Boulding Mark Elliott
EXEC. VP AND CLO
Exempt
Jun 17, 2026
$0.00
2,012
$0.00
30,938
Boulding Mark Elliott
EXEC. VP AND CLO
Exempt
Jun 17, 2026
$396,055.40
8,510
$46.54
113,722
Boulding Mark Elliott
EXEC. VP AND CLO
Sell
Jun 17, 2026
$518,100.00
6,600
$78.50
107,122
Boulding Mark Elliott
EXEC. VP AND CLO
Sell
Jun 17, 2026
$146,594.00
1,850
$79.24
105,272
Boulding Mark Elliott
EXEC. VP AND CLO
Exempt
Jun 17, 2026
$93,638.48
2,012
$46.54
107,284
Boulding Mark Elliott
EXEC. VP AND CLO
Sell
Jun 17, 2026
$133,685.50
1,703
$78.50
105,581
Boulding Mark Elliott
EXEC. VP AND CLO
Sell
Jun 17, 2026
$24,488.25
309
$79.25
105,272
Utter Christine Marie
SVP, CHIEF ACCOUNTING OFFICER
Exempt
Jun 17, 2026
$0.00
19,686
$0.00
15,314
Utter Christine Marie
SVP, CHIEF ACCOUNTING OFFICER
Exempt
Jun 17, 2026
$505,733.34
19,686
$25.69
89,885
Utter Christine Marie
SVP, CHIEF ACCOUNTING OFFICER
Sell
Jun 17, 2026
$1.5M
19,686
$75.56
70,199
Pauwels Eric
CHIEF BUSINESS OFFICER
Sell
Jun 10, 2026
$0.00
17,566
$0.00
0
Pauwels Eric
CHIEF BUSINESS OFFICER
Sell
Jun 10, 2026
$278,325.00
3,711
$75.00
73,411
Pauwels Eric
CHIEF BUSINESS OFFICER
Exempt
Jun 10, 2026
$316,363.66
17,566
$18.01
90,977
Pauwels Eric
CHIEF BUSINESS OFFICER
Sell
Jun 10, 2026
$1.3M
17,566
$75.00
73,411
Boulding Mark Elliott
EXEC. VP AND CLO
Exempt
Apr 06, 2026
$0.00
2,265
$0.00
6,798
Boulding Mark Elliott
EXEC. VP AND CLO
Exempt
Apr 06, 2026
$89,286.30
2,265
$39.42
107,477
Boulding Mark Elliott
EXEC. VP AND CLO
Sell
Apr 06, 2026
$56,644.02
822
$68.91
106,655
Boulding Mark Elliott
EXEC. VP AND CLO
Sell
Apr 06, 2026
$100,649.25
1,443
$69.75
105,212
Golden Lee Scott
EVP & CHIEF MEDICAL OFFICER
Sell
Apr 02, 2026
$56,363.71
829
$67.99
79,115
Chutter Jessica Caroline
Award
Mar 24, 2026
$0.00
3,475
$0.00
3,475
Chutter Jessica Caroline
Award
Mar 24, 2026
$0.00
2,896
$0.00
2,896
Chutter Jessica Caroline
Award
Mar 24, 2026
$0.00
4,000
$0.00
4,000
Chutter Jessica Caroline
Award
Mar 24, 2026
$0.00
3,333
$0.00
7,333
Klein Matthew B.
CHIEF EXECUTIVE OFFICER
Sell
Mar 12, 2026
$170,580.96
2,662
$64.08
396,920
Klein Matthew B.
CHIEF EXECUTIVE OFFICER
Award
Mar 11, 2026
$0.00
12,500
$0.00
399,582
Okey Stephanie
Exempt
Mar 10, 2026
$0.00
1,167
$0.00
0
Okey Stephanie
Exempt
Mar 10, 2026
$0.00
14,000
$0.00
0
Okey Stephanie
Exempt
Mar 10, 2026
$39,246.21
1,167
$33.63
9,167
Okey Stephanie
Sell
Mar 10, 2026
$81,690.00
1,167
$70.00
8,000